Home » Stocks » ACCD

Accolade, Inc. (ACCD)

Stock Price: $44.35 USD -1.60 (-3.48%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
Market Cap 2.65B
Revenue (ttm) 155.57M
Net Income (ttm) n/a
Shares Out 58.54M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 20
Last Price $44.35
Previous Close $45.95
Change ($) -1.60
Change (%) -3.48%
Day's Open 45.40
Day's Range 43.37 - 46.19
Day's Volume 495,779
52-Week Range 28.68 - 65.25

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SEATTLE, March 25, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal amount of 0.50% convertible senior notes due 2026 (the “N...

3 weeks ago - GlobeNewsWire

SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) today provided preliminary unaudited financial results for the fiscal fourth quarter and year ended February 28, 2021 (fiscal ye...

4 weeks ago - GlobeNewsWire

SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced today that it intends to offer, subject to market and other conditions, $250 million aggregate principal ...

4 weeks ago - GlobeNewsWire

SEATTLE, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthca...

2 months ago - GlobeNewsWire

Healthcare technology company Accolade is buying telemedicine startup 2nd.MD to boost its abilities to help users navigate medical plans and second options, CNBC reported. The sale is likely to go forwa...

3 months ago - PYMNTS

Seattle-based Accolade announced Thursday that it will pay $460 million acquire 2nd.

3 months ago - GeekWire

Accolade Inc. said late Thursday it has agreed to buy Innovation Specialists LLC, which does business as 2nd.MD, a "leading" expert medical opinion and medical decision support company based in Houston,...

3 months ago - Market Watch

The addition of 2nd.MD's Expert Medical Opinion services to Accolade's portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade's clinical capabilities and creates the ...

3 months ago - GlobeNewsWire

Just as the digitization of finance has attracted billions in investment and a flurry of M&A, health tech has seen a surge in interest during the pandemic.

3 months ago - CNBC

Accolade integrates workplace benefits into one platform and helps organizations save on employee healthcare costs through a virtual concierge service. The company launched its IPO in July of 2020 and i...

3 months ago - Seeking Alpha

SEATTLE, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthca...

3 months ago - GlobeNewsWire

Accolade, Inc. (ACCD) CEO Rajeev Singh on Q3 2021 Results - Earnings Call Transcript

3 months ago - Seeking Alpha

SEATTLE, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthca...

3 months ago - GlobeNewsWire

SEATTLE, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthca...

3 months ago - GlobeNewsWire

SEATTLE, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthca...

4 months ago - GlobeNewsWire

SEATTLE, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthca...

5 months ago - GlobeNewsWire

SEATTLE, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthca...

5 months ago - GlobeNewsWire

SEATTLE, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthca...

5 months ago - GlobeNewsWire

SEATTLE, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare...

5 months ago - GlobeNewsWire

SEATTLE, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare...

6 months ago - GlobeNewsWire

Accolade, Inc. (ACCD) CEO Rajeev Singh on Q2 2021 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Health benefits technology company Accolade saw revenue rise 24% in the most recent quarter as telehealth usage surges amid the COVID-19 pandemic.

6 months ago - GeekWire

SEATTLE, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthca...

6 months ago - GlobeNewsWire

SEATTLE, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healt...

6 months ago - GlobeNewsWire

Health benefits technology company Accolade says it will provide access to mental health support, including on-demand virtual therapy, in partnership with mental health service Ginger. The partnership, ...

7 months ago - GeekWire

SEATTLE, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healt...

7 months ago - GlobeNewsWire

Accolade's (ACCD) CEO Rajeev Singh on Q1 2021 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Seattle entrepreneur and former Concur president Raj Singh was back in the earnings hot seat Thursday afternoon as the CEO of Accolade, walking analysts and investors through the health benefits technol...

8 months ago - GeekWire

SEATTLE, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health...

8 months ago - GlobeNewsWire

SEATTLE, July 27, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health...

8 months ago - GlobeNewsWire

The Landmark Deal Will Include Geyser Peak, Atlas Peak, XYZin and Outlot WinesNapa, California--(Newsfile Corp. - July 23, 2020) -  Family owned-and-operated fine wine importer Quintessential will becom...

8 months ago - Newsfile Corp

SEATTLE, July 7, 2020 /PRNewswire/ -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare sy...

9 months ago - PRNewsWire

Accolade’s share price is up 38% since its initial public offering on Thursday, marking a successful debut for the health benefits management company at a time of unprecedented uncertainty in the indust...

9 months ago - GeekWire

Accolade - Interesting Tech And Healthcare Offering

9 months ago - Seeking Alpha

Three IPOs raised $2.3 billion this past week, led by Dun & Bradstreet's billion-dollar deal. All three IPOs upsized their deals and priced above the range.

Other stocks mentioned: DNB, LMND
9 months ago - Seeking Alpha

Despite today’s bucket of plus-and-minus economic data, stocks are heading higher in regular trading. And among the shares rising the most are today’s two venture-backed IPOs: Lemonade and Accolade.

Other stocks mentioned: LMND
9 months ago - TechCrunch

Accolade CEO Rajeev Singh on the company's IPO

YouTube video

Rajeev Singh, CEO of Accolade, joins "Squawk on the Street" to discuss the company's IPO.

9 months ago - CNBC Television

Health benefits platform Accolade made its initial public offering Thursday morning, pricing its stock at $22/share, above the expected range of $19 to $21, and raising $220 million at a valuation of $1.

9 months ago - GeekWire

About ACCD

Accolade, Inc. develops and provides technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and with multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. Its customers are primarily employers who provide their employees and their employees' families a single place to turn for their health, health... [Read more...]

Industry
Health Information Services
IPO Date
Jul 2, 2020
Stock Exchange
NASDAQ
Ticker Symbol
ACCD
Full Company Profile

Financial Performance

In 2019, Accolade's revenue was $132.51 million, an increase of 39.76% compared to the previous year's $94.81 million. Losses were -$51.37 million, -9.08% less than in 2018.

Financial Statements

Analyst Forecasts

According to 11 analysts, the average rating for Accolade stock is "Strong Buy." The 12-month stock price forecast is 58.73, which is an increase of 32.42% from the latest price.

Price Target
$58.73
(32.42% upside)
Analyst Consensus: Strong Buy